| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2001060814A3 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | US20020010337 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020007585 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines |
| 01/24/2002 | DE10033016A1 Verfahren zur Herstellung von 3,3-Diarylpropylaminen A process for the preparation of 3,3-Diarylpropylaminen |
| 01/24/2002 | CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/23/2002 | EP1174442A1 Complexes and their use in olefin polymerisation |
| 01/23/2002 | EP1174421A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173420A2 Heterocyclic compounds having antitumor activity |
| 01/23/2002 | EP1173278A1 Metal catalysts and methods for making and using same |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173172A1 Synergistic effects of amlodipine and atorvastatin |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/23/2002 | CN1332726A Pyrrolidine compounds and medicinal utilizaion thereof |
| 01/22/2002 | US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 01/22/2002 | CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor |
| 01/17/2002 | WO2002004476A2 Linked, sequence-specific dna-binding molecules |
| 01/17/2002 | WO2002004417A1 Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid |
| 01/17/2002 | WO2002004416A2 Lactam metalloprotease inhibitors |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | WO2002004399A1 Method for producing 3,3-diarylpropylamines |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method |
| 01/17/2002 | WO2001038303A3 Vitamin d analogues |
| 01/17/2002 | WO2000071493A3 INHIBITORS OF FACTOR Xa |
| 01/17/2002 | US20020007075 Neurological disorders including physically damaged nerves and neurodegenerative diseases, and for treating alopecia and promoting hair growth; Alzheimer's, Parkinson's disease; amyotrophic lateral sclerosis |
| 01/17/2002 | US20020007060 Enzyme inhibitors; connective tissue cells; antiarthritic agents; anticarcinogenic agents |
| 01/17/2002 | US20020007045 For inhibiting the aggregation of blood platelets; 3-(4-Aminomethyl-phenyl)-1-(2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl)-1 -isopropyl-urea for example |
| 01/17/2002 | US20020006971 Extractive distillation |
| 01/17/2002 | US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | DE4423603C2 Verfahren zur Herstellung von N-Alkyl-Lactamen A process for preparing N-alkyl-lactams |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2422520A1 Linked, sequence-specific dna-binding molecules |
| 01/17/2002 | CA2415505A1 Lactam metalloprotease inhibitors |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/16/2002 | EP1172359A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-$g(a) PRODUCTION INHIBITOR |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171123A1 Method for treating neurodegeneration |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0866701B1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound |
| 01/16/2002 | CN1331677A Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/15/2002 | US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/15/2002 | US6339081 Composition and use |
| 01/15/2002 | CA2162135C N-dodecyl heterocyclic compounds useful as industrial microbicides and preservatives |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM |
| 01/10/2002 | WO2002002524A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | WO2002002523A1 Process for preparing distamycin derivatives |
| 01/10/2002 | WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002521A2 Aroyl aminoacyl pyrrole compounds and their pharmaceutical use |
| 01/10/2002 | WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002508A1 Process for the preparation of substituted octanoyl amides |
| 01/10/2002 | WO2001068586A3 α4β1 AND α4β7 INTEGRIN INHIBITORS |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/10/2002 | DE10031288A1 Separation of hydrogen chloride from N-alkyl-2-pyrrolidone comprises refluxing with water with overhead removal of high-purity hydrogen chloride |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2414464A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413241A1 Thrombin or factor xa inhibitors |
| 01/10/2002 | CA2412270A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP0918768B1 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 01/09/2002 | EP0693052B1 Deallylation reagent and deallylation method using said reagent |
| 01/09/2002 | CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 01/09/2002 | CN1330632A Multifunctional imine-esters as novel crosslinkers for surface coatings |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 01/08/2002 | US6337405 Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives |
| 01/08/2002 | US6337398 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 01/08/2002 | US6337394 N-acyl-heterocycle-carboxyamides that are n-substituted with amidino-substituted rings; competitive inhibitors of thrombin; anticoagulants |
| 01/08/2002 | US6337343 Amino acid derivatives |
| 01/08/2002 | CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/08/2002 | CA2095136C Anti-reversion coagents for rubber vulcanization |
| 01/08/2002 | CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators |